This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Boas, R.A. Search for Related Content PubMed PubMed Citation Articles by Boas, R.A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Intra Arterial Ketanserin in Peripheral Vascular Disease

Department of Pharmacology and Clinical Pharmacology, University of Auckland School of Medicine, Auckland, New Zealand

An open study utilizing a serotonergic S₂ antagonist, ketanserin, in a single 10mg intra arterial dose, was undertaken in eleven patients suffering various micro-vascular ischemic diseases. Ipsilateral limb blood flow improved 50%, skin temperatures rose 2.5°C and venous oxygen tensions measured in the dis eased foot showed modest elevation. The changes were significant and compara ble to those achieved with chemical sympathectomy. These findings suggest ketanserin may have a place in the treatment of microvascular ischemic disease. However, systemic and contralateral flow induced changes suggested regional specificity was not obtained with arterial injection.

Angiology, Vol. 37, No. 4, 267-271 (1986)
DOI: 10.1177/000331978603700401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C.A. Caputi, G. De Carolis, and C. Tomasetti Regional Intravenous Ketanserin and Guanethidine Therapy in Raynaud's Phenomenon Angiology, June 1, 1991; 42(6): 473 - 480. [Abstract] [PDF]